Advertisements

Amiloride Hydrocloride

Quick links to important sections

Amiloride Hydrocloride

Selected form

Advertisements

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Amiloride Hydrocloride

Quick Facts

Property Description
Active Ingredient Amiloride (as the monohydrochloride dihydrate salt)
Form Tablet (Oral)
Pharmacological Class Potassium-Sparing Diuretic; Antihypertensive Agent
General Purpose Fluid volume reduction; Potassium conservation
Origin Synthetic Organic Compound

Amiloride Hydrochloride (Amilorid) is a synthetic, prescription-only medication classified as a Potassium-Sparing Diuretic. The drug's core compound, Amiloride, is an International Nonproprietary Name (INN) substance, which is administered orally in the form of a tablet. It is characterized by its ability to manage the body's fluid and electrolyte balance, which is fundamental to its role as an antihypertensive agent.


Amiloride's Unique Pharmacological Classification

Amiloride Hydrochloride belongs to a unique subclass of diuretics defined by its primary action: increasing the excretion of water and sodium by the kidneys while simultaneously conserving potassium. This medication acts through the targeted inhibition of Epithelial Sodium Channels (ENaC), a mechanism independent of aldosterone activity, which is clinically recognized for providing a sustained potassium-sparing effect. Amiloride's antikaliuretic activity is crucial in preventing the low potassium levels (hypokalemia) often induced by other high-potency diuretics. This ability to protect the body's essential potassium balance during fluid management is the drug's key differentiating feature.


Single Agent or Combination Product?

While available as a single-agent formulation, Amiloride is frequently used as a component in combination products alongside a partner diuretic, such as hydrochlorothiazide. This adjunctive treatment strategy is designed to maximize fluid reduction while leveraging Amiloride's potassium-sparing effect to mitigate the risk of electrolyte imbalance. This utilization underscores the drug's specialized role in providing balanced management of fluid volume and high blood pressure.

Regulatory References

  1. Amiloride Hydrochloride DailyMed Label
Advertisements

What side effects are possible with Amiloride Hydrocloride?

Possible Side Effects and Safety Information

The safety profile of Amiloride Hydrochloride is primarily characterized by the risk of metabolic disturbances, particularly Hyperkalemia (elevated serum potassium), which is classified as a common adverse reaction when the drug is used without a potassium-excreting diuretic, according to official regulatory labeling. This risk necessitates strict safety constraints.

Amiloride is contraindicated and should not be used in individuals with pre-existing hyperkalemia, severe progressive renal disease, diabetic nephropathy, or when concurrently taking other potassium-sparing diuretics or potassium supplements. Increased risk of hyperkalemia is also documented when the medicine is co-administered with certain blood pressure medications, such as ACE inhibitors.

Adverse reactions are grouped by the physiological system affected:

  • Metabolism and Nutrition Disorders: Hyperkalemia, Hyponatremia.
  • Gastrointestinal Disorders: Common effects include nausea, vomiting, abdominal pain, and diarrhea. Serious reactions can include gastrointestinal bleeding and jaundice in susceptible patients.
  • Nervous System & Psychiatric Disorders: Common reactions include headache, weakness, and fatigue, while uncommon effects listed include dizziness, mental confusion, and depression.

Serious adverse reactions documented in regulatory sources include potentially fatal Hyperkalemia and the risk of Hepatic Encephalopathy in patients with severe pre-existing liver disease. Population-specific safety notes indicate that older adults and patients with renal impairment are at a greater risk of developing hyperkalemia. The safety and effectiveness of the medicine have not been established in the pediatric population.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The information below summarizes the officially documented descriptions and mandatory actions for Amiloride Hydrochloride overdose, based strictly on government regulatory labeling.

Overdose manifestations are primarily characterized by severe electrolyte imbalance and dehydration. The most serious complication noted in regulatory documents is potentially fatal hyperkalemia, which is an excessive level of potassium in the blood. Clinical signs associated with this life-threatening risk include muscular weakness, paresthesias, and ECG abnormalities such as QRS complex widening and peaked T waves, which may lead to bradycardia or shock.

Overdose Outcome Documented Manifestation
Primary Risk Potentially fatal hyperkalemia and resulting cardiac effects
Clinical Signs Muscular weakness, Paresthesias, Flaccid paralysis
Severe Outcomes Shock, Severe ECG abnormalities

Urgent medical attention must be sought immediately if an overdose is suspected or if a patient exhibits signs of severe electrolyte imbalance. Regulatory guidance mandates immediate discontinuation of the medication and close patient observation. Furthermore, specific supportive procedures are required when serum potassium levels exceed a critical threshold, including the use of intravenous sodium bicarbonate, glucose with insulin, or cation exchange resins, as no specific antidote is available. The risk of hyperkalemia is particularly accentuated in the presence of renal impairment.

Advertisements

Therapeutic Uses of Amiloride Hydrocloride

What Amiloride Hydrochloride Treats: Main Uses and Benefits

Amiloride Hydrochloride is commonly used to help manage the symptomatic burden associated with conditions that cause fluid retention. Specifically, it may be part of symptomatic management for conditions such as congestive heart failure, hepatic cirrhosis with ascites, and hypertension. This medication is applied across domains where additional symptomatic support is needed, primarily addressing symptoms related to systemic imbalance where excess fluid (edema) causes discomfort.


Supportive Management for Symptom Clusters

This medicine helps address symptom clusters that may become intense or disruptive, such as visible swelling, which may interfere with daily functioning and create noticeable physiological strain. It is relevant in conditions characterized by periods of heightened symptoms, often used as an adjunct to help manage fluid and blood pressure.

Amiloride is applied within clinical settings that involve acute or unstable symptom patterns. It contributes to easing the overall symptom load by supporting the patient during episodes of heightened discomfort.

Quick Fact: Supports management of Fluid Retention Symptoms


General Patient-Oriented Benefits

Amiloride is commonly used across conditions presenting with acute episodes and where functional stability becomes affected. It may assist with maintaining functional stability in long-term care plans for conditions like high blood pressure and heart conditions, supporting general well-being during symptomatic phases.

Advertisements

Eligibility and Restrictions for Use

Amiloride Hydrochloride is permitted for use in adults for conditions such as hypertension, congestive heart failure, and hepatic cirrhosis with ascites, typically as adjunctive therapy. Official regulatory documents define strict limitations based on the drug's potassium-sparing action. The medicine is contraindicated and must not be used in patients with pre-existing Hyperkalemia (elevated serum potassium levels). Absolute prohibitions also extend to patients with Anuria, Acute or Chronic Renal Insufficiency, or Diabetic Nephropathy. Furthermore, concurrent use with other potassium-conserving agents or potassium supplementation is forbidden.

Special restrictions apply to vulnerable groups. Safety and efficacy have not been established for children under 18 years of age. Use in older adults requires particular caution. Eligibility is also generally restricted or not recommended during both pregnancy and lactation, based on official labeling. Use in patients with Diabetes Mellitus or severe Impaired Hepatic Function is conditional and requires careful consideration.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction Scope

Category Entity/Statement
Medicinal product categories with documented interactions Potassium-Sparing Diuretics, ACE Inhibitors, Angiotensin II Receptor Antagonists (ARBs), Non-Steroidal Anti-Inflammatory Agents (NSAIDs), Lithium, Immunosuppressants.
Specific interacting medicines (if explicitly listed) Spironolactone, Triamterene, Eplerenone, Indomethacin, Lithium, Cyclosporine, Tacrolimus.
Mechanistic basis of interactions (only if stated in label) Pharmacodynamic Reinforcement of Potassium, Reduced Renal Clearance of Lithium, Antagonism of Diuretic Effect (by NSAIDs).
Timing-based interaction rules (if applicable) None documented in official labels.
Population-specific interaction notes (if applicable) Hyperkalemia risk is heightened in patients with Impaired Renal Function, Diabetes Mellitus, or Acidosis.
Interaction-related restrictions Contraindicated with Potassium Supplements (including salt substitutes), other Potassium-Sparing Diuretics, and Eplerenone.

Interaction Classifications (High-Level)

Classification Description
Interaction severity classification (as defined in official documents) Contraindicated (Potassium Agents); Significant/Monitor Closely (ACE-I, ARBs, Lithium, NSAIDs).
Regulatory basis (EMA / FDA / etc.) FDA Prescribing Information, Summary of Product Characteristics (SmPC).
Interaction-context constraints (as defined in official documents) Requires frequent monitoring of serum potassium when combined with agents such as ACE Inhibitors or ARBs.

Official Interaction Statements

Co-administration with Potassium Supplements (including salt substitutes) or other Potassium-Sparing Diuretics is contraindicated due to the high risk of hyperkalemia. ACE Inhibitors and ARBs also increase the risk of hyperkalemia. NSAIDs (e.g., Indomethacin) can reduce the diuretic effect and may increase potassium levels. Amiloride reduces the renal clearance of Lithium, which significantly increases the risk of Lithium toxicity.

Regulatory documentation defines this drug’s interaction structure primarily by identifying substances that create Pharmacodynamic Reinforcement of Potassium Retention and by detailing specific Reduced Clearance interactions. This structure establishes mandatory contraindications and necessitates requirements for frequent monitoring when co-administering certain blood pressure or mood stabilizing agents.

Advertisements

Mechanism of Action

Direct Inhibition of Epithelial Sodium Channels (ENaC)

Amiloride Hydrochloride's mechanism centers on modulating fluid and electrolyte transport in the kidney through ion channel interference. It acts as a specific inhibitor by binding to and physically blocking the Epithelial Sodium Channel ( ENaC) located on the principal cells in the late distal convoluted tubule and the collecting duct. This targeted action inhibits the reabsorption of sodium ions ( Na^+) from the tubular filtrate.

Regulation of Potassium Homeostasis via Electrical Potential

By blocking Na^+ reabsorption, Amiloride diminishes the negative electrical potential difference in the tubular lumen, which normally drives the secretion of positively charged potassium ( K^+) and hydrogen ( H^+) ions. This modulation of the electrical gradient reduces the excretion of K^+ and H^+, leading to their retention, a mechanism that is independent of aldosterone.

Mechanistic Role in Combination Therapy

When employed in combination therapy, Amiloride's K^+-sparing mechanism counteracts the kaliuretic effect of partner diuretics. This synergy results in additive Na^+ and water excretion (natriuresis and diuresis) combined with K^+ retention.

Advertisements

Dosage and Administration Information

How to Use Amiloride Hydrochloride

Amiloride Hydrochloride is administered exclusively by the oral route, typically supplied as a 5 mg tablet, often utilized in fixed-dose combination products. The tablet must be swallowed whole with liquid.

The standard administration pattern begins with an initial dose, commonly 5 mg taken once daily. Based on the necessary response and monitoring, the dosage may be adjusted (titrated) within the usual maintenance range of 5 mg to 10 mg daily, up to a maximum of 20 mg per day. Although the usual frequency is once daily, in some situations, the dose may be divided and administered twice per day.

Usage guidelines stipulate that the medication should be taken with food and at the same time each day to maintain consistency. If a dose is missed, the protocol is to skip it if it is nearly time for the next scheduled dose; a double dose must never be taken.

Specific usage constraints apply to certain populations: the drug is not recommended for pediatric patients (under 18) as safety and efficacy have not been established. Use is also restricted or not advised in patients with severe functional renal impairment. Throughout the course of treatment, procedural use requires the frequent and continuing monitoring of serum electrolytes and kidney function.

Advertisements

Recent Clinical Evidence

Research Evidence: Overview of Studies

Research has investigated the potential of Amiloride Hydrochloride to affect sodium and fluid balance, particularly when used in combination with other diuretic agents. The primary goal of these studies is to assess the potential for reducing potassium loss (hypokalemia) often associated with thiazide and loop diuretics. Amiloride is structurally a potassium-sparing diuretic, and its co-administration has been evaluated in the context of standard care for managing hypertension and edema.


Core Evidence and Safety Profile

A major Randomized Controlled Trial (RCT) assessed the relationship between the drug's use and the stabilization of serum potassium levels, especially in patients with existing fluid retention. Researchers noted an association between the drug's co-administration and the preservation of serum potassium concentrations over the investigation period, compared to placebo or monotherapy with a potassium-wasting diuretic. The effects of the combination treatment on specific clinical measures, such as blood pressure reduction and edema resolution, were also investigated. The safety profile reported in the studies mainly consisted of data collected from adult participants with hypertension or congestive heart failure.


Future Directions

Studies are currently examining whether the drug may have an effect on specific ion channels beyond its primary renal target, including potential research into conditions like cystic fibrosis or certain neurological disorders. Research confirms that the treatment has not been studied in populations lacking the approved indications or in individuals with severe, pre-existing hyperkalemia.

Key Studies & References

  1. Amiloride: Drug Information
  2. National Institutes of Health (NIH) Clinical Trials on Amiloride for Cystic Fibrosis
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Amiloride Hydrochloride (FAQ)


Q: What is the main difference between Amiloride and a thiazide diuretic?

Official classifications describe Amiloride as a potassium-sparing diuretic because its main action is to conserve potassium ( K^+) in the body. In contrast, other types, such as thiazide diuretics, are known to increase the loss of K^+ during fluid management. Amiloride is often combined with other diuretics because its potassium-conserving action can mitigate the potential for potassium loss caused by those diuretics.


Q: How does Amiloride help manage fluid retention (edema) in the body?

According to official product information, Amiloride helps manage fluid retention by acting on the kidneys to increase the excretion of both sodium and water. This process is medically termed diuresis. Unlike some other diuretics, Amiloride works to maintain the body’s potassium balance simultaneously.


Q: Does Amiloride help lower blood pressure on its own, or is it mainly an add-on treatment?

Regulatory documents classify Amiloride as an antihypertensive agent, meaning it is used for blood pressure management. While it is available as a single agent for certain uses like fluid retention, it is very frequently used as an adjunctive (add-on) treatment alongside other diuretics. This combination is intended to provide comprehensive management of blood pressure and fluid volume.


Q: Does Amiloride interact with common over-the-counter pain relievers (NSAIDs) like ibuprofen?

Official drug labels indicate that co-administration with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as ibuprofen, may reduce Amiloride's diuretic effect. Regulatory documents indicate this combination may also increase the risk of hyperkalemia (high potassium levels) and may lead to changes in kidney function.


Q: What specific signs of high potassium (hyperkalemia) should a patient be aware of?

Regulatory sources describe signs of high potassium (hyperkalemia) that have been documented with the drug’s use. These may include feelings of tingling or numbness (paresthesias), unexplained muscle weakness or fatigue, an irregular heartbeat, and flaccid paralysis of the limbs.


Q: Is Amiloride considered safe to use during pregnancy, according to official classifications?

Amiloride is assigned to FDA Pregnancy Category B. The official product information indicates that the drug's use during pregnancy should be determined by a healthcare provider after the clinical need is clearly established, as controlled studies in human pregnancy are unavailable.


Q: What are the warnings about Amiloride use for patients who have liver problems like cirrhosis?

While Amiloride is indicated for use in patients with hepatic cirrhosis and fluid accumulation (ascites), regulatory warnings advise extreme caution. Official warnings note the potential for the drug to induce a serious neurological condition called Hepatic Encephalopathy in patients with severe pre-existing liver disease.


Q: How does Amiloride interact with Lithium medication, according to official documents?

Official drug interaction statements indicate that Amiloride reduces the renal clearance (the rate at which it is removed by the kidneys) of Lithium. This action causes increased concentrations of Lithium in the body, which significantly raises the risk of Lithium toxicity.


Q: How quickly does Amiloride usually start working after the first dose?

Based on official pharmacological data, the diuretic action of Amiloride typically begins within approximately two hours of taking an oral dose. The effect on electrolyte excretion generally reaches its peak between six to ten hours and usually lasts for about 24 hours.


Q: If I feel well, is it necessary to continue taking Amiloride for high blood pressure as prescribed?

Amiloride is prescribed for chronic conditions such as high blood pressure and heart failure, and official documents emphasize the need for continued monitoring of electrolytes throughout treatment. Regulatory documentation emphasizes the need for continued monitoring of electrolytes throughout treatment, particularly when managing chronic conditions like high blood pressure.


Q: Does Amiloride have any documented effects on blood sugar or cholesterol levels?

Official product information notes that Amiloride tablets may be able to affect the results of a glucose tolerance test. Furthermore, patients with diabetes mellitus are considered to be at a heightened risk for hyperkalemia (high potassium levels) when using the drug.


Q: Is Amiloride used to treat conditions other than high blood pressure and heart failure?

In addition to high blood pressure, Amiloride is officially indicated for use in managing fluid retention (edema) associated with congestive heart failure and hepatic cirrhosis with ascites. It is also used as an agent to reduce potassium loss when patients are taking other types of diuretics.


Q: Can Amiloride affect the results of other medical or laboratory tests?

Regulatory information indicates that Amiloride may affect the results of several laboratory tests, including the glucose tolerance test. Changes in blood test results related to liver function, red or white blood cell counts, and sodium or potassium levels have also been reported.


Q: Can Amiloride make pre-existing conditions like gout or lupus symptoms worse?

Regulatory information for combination products containing Amiloride includes specific warnings regarding use in patients who have a history of conditions such as gout or systemic lupus erythematosus.


Q: Does Amiloride have any known effects on a person's sexual function or libido?

Adverse reactions listed in official documents include a decrease in libido (sexual desire) and erectile dysfunction.


Q: What is the official information regarding hair loss as a potential side effect?

Hair loss, medically termed alopecia, is documented as a rare side effect in the official regulatory documentation for Amiloride.


Q: What are the signs of a serious, but rare, side effect like acidosis or pancreatitis?

Official information lists Metabolism and Nutrition Disorders as a system that can be affected by the drug. Warnings advise special care for patients whose existing medical conditions are associated with having too much acid in the blood, a state known as acidosis.


Q: Can taking Amiloride cause temporary changes in mood or confusion?

Reported side effects listed under Nervous System and Psychiatric Disorders include feelings of confusion, mental confusion, and changes in mood or personality.


Q: Are there any limitations on driving or operating machinery while taking Amiloride?

Official patient information indicates that if a person experiences dizziness or feels generally unwell while taking Amiloride, activities such as driving or operating dangerous machinery may be affected.

Advertisements

How should Amiloride Hydrocloride be stored and disposed of?

Storage and Disposal Requirements

Amiloride Hydrochloride tablets must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). The medication should be kept in the original container and the container must remain tightly closed to protect the tablets. Like all medications, Amiloride must be stored out of the reach of children.

Disposal

To dispose of expired or unused Amiloride Hydrochloride, the official guidance recommends using a drug take-back program. You should not flush this medication down the toilet unless specifically instructed by a regulator. Disposal must follow all local requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amiloride Hydrocloride found in:

A-Z Index: